Last reviewed · How we verify
NCT04604990
National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia
trial in SLE (Systemic Lupus) in 1,000 participants. Currently enrolling.
1 November 2050
Quick facts
| Lead sponsor | King Saud University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 20 December 2020 |
| Primary completion | 1 November 2050 |
| Estimated completion | 1 November 2050 |
| Sites | 1 location across Saudi Arabia |
Conditions studied
- SLE (Systemic Lupus) — all drugs for SLE (Systemic Lupus) →
Sponsor
King Saud University
Who can join
19 and older, any sex, with SLE (Systemic Lupus). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
SLE disease in Saudi Arabia is yet not well defined especially in a population with high consanguinity and high inbreeding coefficient . Up until now, there has been no prospective cohort study for SLE patients in Saudi Arabia. As a result, current published literature is focused on retrospective chart reviews which are subjected to many forms of bias. so the investigator proposed this prospective registry which will follow open cohort study design aiming to provide better understanding of disease presentation, course and outcomes especially if complemented by detailed immunological, molecular, genetic and microbiome data.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
National systemic lupus erythematosus prospective cohort in Saudi Arabia: A study protocol.
Almaghlouth IA, Almaghlouth IA, Hassen LM, Alahmari HS, et al · · 2021 · cited 12× · PMID 34397699 · DOI 10.1097/md.0000000000026704 -
The Prevalence and Effect of Cosmetic Procedures on Patients with Rheumatic Diseases: A Cross-Sectional Survey.
Almaghlouth I, Almalag HM, AlEnezy RB, AlEnezy S, et al · · 2026 · cited 1× · PMID 41682228 · DOI 10.3390/healthcare14030378
Verify or expand the search:
- PubMed search for NCT04604990
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for SLE (Systemic Lupus)
Currently open trials in the same condition.
- NCT07196072 — A Multi-component, Person-centered, and Yoga-based Coaching Program for Lupus Chronic Pain · NA · active not recruiting
- NCT06925542 — A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease · Phase 1 · recruiting
- NCT06548607 — Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases · EARLY_PHASE1 · recruiting
- NCT06056921 — Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease · Phase 1 · recruiting
- NCT05866861 — A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus · Phase 1 · active not recruiting
Other King Saud University trials
Trials by the same sponsor.
- NCT07500493 — Tele-Rehabilitation in Adults With Cystic Fibrosis · NA · not yet recruiting
- NCT07324044 — Chrono-ALIGN: A Chronotype-Based Chrono-Nutrition Intervention in Post-Bariatric Patients · NA · not yet recruiting
- NCT07288385 — Investigating the Feasibility of Combining Virtual Reality and Bilateral Transcranial Direct Stimulation to Improve Uppe · NA · recruiting
- NCT07475195 — Oral Probiotics and Denture Care in Saudi Arabia: Evaluating Knowledge, Practices, and the Future of Innovative Hygiene · completed
- NCT07159152 — Effects of Coffee Versus Hibiscus Tea Consumption During Prolonged Sitting on Blood Pressure and Heart Rate · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04604990 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by King Saud University
- Last refreshed: 1 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04604990.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing